Don't leave, TurboMice™ is coming to you!
Connecting to server... 0%
  • 4-Week Delivery: World’s fastest custom mouse model development.
  • TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
  • Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
  • Validated Quality: Guaranteed high precision and model viability.
Partners' Projects

Vstm3 (TIGIT) Humanized Mouse Model

Category
Strain Name

Vstm3 (TIGIT) Humanized Mouse Model

Editing Type

Humanized

Gene Name

Tigit (mouse T cell immunoreceptor with Ig and ITIM domains)

Gene Synonyms

Vstm3 / VSIG9 / WUCAM

Strain Background

C57BL/6N

NCBI No.

Mouse Tigit:Gene ID: 100043314 / MGI:3642260
Human TIGIT:Gene ID: 201633 / HGNC:26838(MIM:612859)

1. Immune checkpoint function and mechanism Investigating the expression pattern and regulatory mechanism of human TIGIT (VSTM3) in T cells, NK cells and other immune populations; defining its role as an inhibitory checkpoint in suppressing immune responses and sustaining immune tolerance.

2. Tumor immunotherapy evaluation Assessing the efficacy of blocking antibodies, antagonists or agonists targeting human TIGIT in tumour immunotherapy; studying TIGIT expression in the tumour microenvironment and its impact on tumour-infiltrating lymphocyte function, and exploring combination regimens.

3. Autoimmune and inflammatory disease Investigating the role of TIGIT in autoimmune conditions such as rheumatoid arthritis and multiple sclerosis; testing TIGIT-directed strategies for damping excessive immune responses and alleviating autoimmune pathology.

4. Infection immunity and vaccines Studying how TIGIT regulates adaptive immune responses during acute and chronic infection; assessing TIGIT blockade for enhancing anti-infective immunity and improving vaccine efficacy.

The Vstm3 (TIGIT) Humanized Mouse Model is generated by genetic engineering so that mice express the human VSTM3/TIGIT protein in place of, or in addition to, the mouse gene. TIGIT is an immunoregulatory molecule expressed on the surface of immune cells — particularly T cells and NK cells — belonging to the immunoglobulin superfamily, where it acts as an inhibitory checkpoint receptor. The model reconstructs human TIGIT expression and immunoregulatory function in mice, providing a humanized system for studying its role in tumour immunity, autoimmunity and infection. It allows the mechanisms by which TIGIT controls T cell and NK cell activation to be dissected, and permits preclinical evaluation of monoclonal antibodies, bispecific antibodies or cell therapies targeting human TIGIT in reversing immune suppression, enhancing anti-tumour immunity or modulating autoimmune responses. Human immune system co-humanization and specific isoform configurations are available on request.

  1. The checkpoint a human antibody actually binds. Anti-TIGIT antibodies are raised against the human receptor and frequently do not cross-react with mouse TIGIT; here the target is human, so binding and pharmacology transfer.
  2. Surface expression where the biology happens. TIGIT sits on T and NK cells, so checkpoint readouts are taken on the cells that mediate the response rather than on a surrogate.
  3. Combination studies are the point. TIGIT blockade is developed alongside PD-1/PD-L1 axis agents; a humanized line makes those combinations testable in one animal.
  4. Both disease directions. The same genotype serves tumour immunotherapy and autoimmune or anti-infective questions — the two ends of checkpoint pharmacology.
  5. Co-humanization available. Human immune system co-humanization and specific isoform configurations can be requested, which extends the model to reconstitution settings.

FAQ

Game-changing benefits?

While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.

•Free initial design proposal with zero obligations.​
•Request a free quote!

All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.

This website uses cookies

We use cookies to personalize content, provide social media features, and analyze our traffic. We also share information about your use of our site with our analytics partners. You can change your preferences at any time. For more information, please see our Privacy Policy Cookie Policy